Monday, 6 July 2020

BioLargo completes prototype for PFAS treatment system, ready for pilot testing




BioLargo (OTCQB: BLGO) CEO Dennis Calvert Calvert joined Steve Darling from Proactive with news the company has completed manufacturing on its first prototype unit of their patented BioLargo AEC to tackle PFAS contamination.

Calvert told Proactive the next step and he also told investors about a new product from their Clyra Medical called Clyraguard.

No comments:

Post a comment